# OXCARBAZEPINE
> **ANDA216749** · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2023-10-20
## Drug
- **FDA Application Number:** ANDA216749
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OXCARBAZEPINE
- **Generic name:** OXCARBAZEPINE
- **Active ingredients:** OXCARBAZEPINE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** HETERO LABS LTD III
- **Manufacturer:** NorthStar RxLLC
- **First approval:** 2023-10-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216749)
---
*AI Analytics · CC0 1.0*